316 related articles for article (PubMed ID: 18096504)
1. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices.
King AR; Duranti A; Tontini A; Rivara S; Rosengarth A; Clapper JR; Astarita G; Geaga JA; Luecke H; Mor M; Tarzia G; Piomelli D
Chem Biol; 2007 Dec; 14(12):1357-65. PubMed ID: 18096504
[TBL] [Abstract][Full Text] [Related]
2. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
3. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
4. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.
Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ
Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats.
Carloni S; Alonso-Alconada D; Girelli S; Duranti A; Tontini A; Piomelli D; Hilario E; Alvarez A; Balduini W
Pediatr Res; 2012 Oct; 72(4):400-6. PubMed ID: 22821058
[TBL] [Abstract][Full Text] [Related]
6. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.
Dinh TP; Kathuria S; Piomelli D
Mol Pharmacol; 2004 Nov; 66(5):1260-4. PubMed ID: 15272052
[TBL] [Abstract][Full Text] [Related]
7. Brain monoglyceride lipase participating in endocannabinoid inactivation.
Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
9. Assay of Monoacylglycerol Lipase Activity.
Jung KM; Piomelli D
Methods Mol Biol; 2016; 1412():157-68. PubMed ID: 27245902
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of monoacylglycerol lipase as novel analgesics.
Hohmann AG
Br J Pharmacol; 2007 Mar; 150(6):673-5. PubMed ID: 17293886
[TBL] [Abstract][Full Text] [Related]
11. Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons.
Dotsey EY; Jung KM; Basit A; Wei D; Daglian J; Vacondio F; Armirotti A; Mor M; Piomelli D
Chem Biol; 2015 May; 22(5):619-28. PubMed ID: 26000748
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of Langerhans.
Li C; Vilches-Flores A; Zhao M; Amiel SA; Jones PM; Persaud SJ
Cell Physiol Biochem; 2012; 30(2):347-58. PubMed ID: 22739267
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells.
Muccioli GG; Xu C; Odah E; Cudaback E; Cisneros JA; Lambert DM; López Rodríguez ML; Bajjalieh S; Stella N
J Neurosci; 2007 Mar; 27(11):2883-9. PubMed ID: 17360910
[TBL] [Abstract][Full Text] [Related]
15. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
[TBL] [Abstract][Full Text] [Related]
16. Refined homology model of monoacylglycerol lipase: toward a selective inhibitor.
Bowman AL; Makriyannis A
J Comput Aided Mol Des; 2009 Nov; 23(11):799-806. PubMed ID: 19543978
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and reversible monoacylglycerol lipase inhibitors.
King AR; Dotsey EY; Lodola A; Jung KM; Ghomian A; Qiu Y; Fu J; Mor M; Piomelli D
Chem Biol; 2009 Oct; 16(10):1045-52. PubMed ID: 19875078
[TBL] [Abstract][Full Text] [Related]
18. The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.
Cipriano M; Gouveia-Figueira S; Persson E; Nording M; Fowler CJ
BMC Res Notes; 2014 Jul; 7():441. PubMed ID: 25012825
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.
Björklund E; Norén E; Nilsson J; Fowler CJ
Br J Pharmacol; 2010 Dec; 161(7):1512-26. PubMed ID: 20735405
[TBL] [Abstract][Full Text] [Related]
20. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.
Straiker A; Hu SS; Long JZ; Arnold A; Wager-Miller J; Cravatt BF; Mackie K
Mol Pharmacol; 2009 Dec; 76(6):1220-7. PubMed ID: 19767452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
